NAD+ (500mg & 1000mg) (500mg Vial)
2 × $86.00 
BPC-157 5 & 10mg (10mg Vial)
1 × $56.00 
KLOW Blend 80mg: KPV/GHK-Cu/BPC-157/TB-500 (10/50/10/10mg)
1 × $163.00 Subtotal: $391.00
$140.00
This product name (e.g. GLOW, KLOW, Wolverine) is only an informal catalog nickname, used so researchers can find this blend. It is not a claim of any cosmetic, beauty, skin, anti-aging, or therapeutic benefit. Supplied strictly for laboratory research use only — not for human, veterinary, cosmetic, or therapeutic use.
GHK-Cu 50 mg
BPC-157 10 mg
TB-500 10 mg
Three research peptides in one vial — GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg): 70 mg of sterile lyophilized powder for in-vitro tissue-repair and matrix research.
Tested by Freedom Diagnostics TestingHPLC purity + LC-MS identityLot-matched COA on-site
For research use only. This product is a laboratory research chemical. It is not for human or veterinary use, not a drug, supplement, or food, and not intended to diagnose, treat, cure, or prevent any disease. Sold only to qualified researchers and institutions.
GLOW Blend is a research-grade three-peptide repair blend supplied in a single co-lyophilized vial — GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg), 70 mg combined. Each component is studied for a different layer of the regenerative cycle: GHK-Cu for copper-mediated extracellular-matrix and collagen signaling, BPC-157 for angiogenic and growth-factor pathways, and TB-500 (acetylated Thymosin Beta-4) for actin-driven cell migration.
Research areas where laboratories buy GLOW for in vitro work include how the three peptides interact at fibroblast signaling and extracellular-matrix deposition, single-peptide versus multi-peptide comparisons on fibroblast migration and proliferation, NO / VEGFR2 and FAK-paxillin pathway activity in soft-tissue-repair models, and copper-mediated antioxidant-pathway profiling. The material supplied here is research-grade for in vitro laboratory study only.
Reported31 May 2026
Endotoxin (USP <85>)Within limits ✓
Chemical & structural reference data — specifications, molecular profile and handling.
Product Specifications
Molecular Profile
Storage & Handling
In solution2–8 °C; aliquot & freeze
FDA StatusNone of GLOW Blend’s three components — GHK-Cu, BPC-157, or TB-500 — is approved by the FDA as a drug for any indication. The research-grade blend supplied by Koi Peptides is synthesized independently for in vitro laboratory research only — not formulated, packaged, or labeled for human use, not equivalent to or a substitute for any approved drug product, and not authorized for any human or veterinary indication.
WADA Anti-Doping StatusThe TB-500 component (thymosin β-4) is a prohibited substance under WADA Section S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), prohibited at all times. Athletes subject to anti-doping rules should treat GLOW Blend accordingly and confirm current status with their governing body. GHK-Cu and BPC-157 are not specifically named on the current Prohibited List; the presence of TB-500 makes the blend relevant under S2.
Compounding Pharmacy StatusKoi Peptides is a chemical research supplier — not a compounding pharmacy or outsourcing facility under sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act — and supplies no compounded preparations of any kind. GLOW Blend is research-grade material for in vitro laboratory study, not a compounded preparation for human use.
For research use only. Not for human or veterinary use. GLOW Blend is supplied to qualified research professionals for in vitro laboratory study. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Koi Research Labs LLC is a chemical supplier, not a compounding pharmacy under 503A nor an outsourcing facility under 503B of the Federal Food, Drug, and Cosmetic Act. By purchasing, the buyer agrees this material will not be introduced into humans or animals. Misuse may violate federal, state, or local laws.
Reviews
There are no reviews yet.